Jul 27, 2011, 06.17 PM IST
Parenteral Drug Jun '11 sales at Rs 45.43 crore
Parenteral Drugs (India) has reported a sales turnover of Rs 45.43 crore and a net loss of Rs 5.43 crore for the quarter ended Jun '11
Like this story, share it with millions of investors on M3
Parenteral Drug Jun '11 sales at Rs 45.43 crore
Parenteral Drugs (India) has reported a sales turnover of Rs 45.43 crore and a net loss of Rs 5.43 crore for the quarter ended Jun '11
Like this story, share it with millions of investors on M3
Parenteral Drug Jun '11 sales at Rs 45.43 crore
Parenteral Drugs (India) has reported a sales turnover of Rs 45.43 crore and a net loss of Rs 5.43 crore for the quarter ended Jun '11
Share .
Email .
Print .
A+A-
Parenteral Drugs (India) has reported a sales turnover of Rs 45.43 crore and a net loss of Rs 5.43 crore for the quarter ended Jun '11.
| For the quarter ended Jun 2010 the sales turnover was Rs 98.92 crore and net profit was Rs 8.55 crore.
|
|
| | Quarterly Results of Parenteral Drugs (India) | -------- in Rs. Cr. -------- |
|
| Jun '10 | | | Mar '11 | Jun '11 | | Sales Turnover | 98.92 | | | 38.89 | 45.43 | | Other Income | -- | | | -- | -- | | Total Income | 98.92 | | | 38.89 | 45.43 | | Total Expenses | 80.08 | | | 66.64 | 39.72 | | Operating Profit | 18.84 | | | -27.75 | 5.71 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 18.84 | | | -27.75 | 5.71 | | Interest | 4.11 | | | 7.46 | 8.03 | | PBDT | 14.73 | | | -35.21 | -2.31 | | Depreciation | 1.97 | | | 2.47 | 2.60 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 12.76 | | | -37.68 | -4.91 | | Tax | 4.21 | | | 0.17 | 0.52 | | Net Profit | 8.55 | | | -37.85 | -5.43 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 4.41 | | | -- | -- | | Book Value | -- | | | -- | -- | | Equity | 19.40 | | | 25.87 | 25.87 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
